GLIDAPAFLOZIN M 10/500: Optimizing Diabetes Management with Dapagliflozin (10mg) and Metformin (500mg) SR...

GLIDAPAFLOZIN M 10/500 

Dapagliflozin (10mg), Metformin (500mg) SR

GLIDAPAFLOZIN M 10/500 represents a groundbreaking combination therapy in the realm of diabetes management, harnessing the synergistic benefits of Dapagliflozin (10mg) and Metformin (500mg) SR. This innovative formulation offers a multifaceted approach to glycemic control, targeting distinct pathways involved in glucose metabolism. In this comprehensive guide, we delve into the intricacies of GLIDAPAFLOZIN M 10/500, exploring its mechanism of action, therapeutic efficacy, dosage considerations, potential side effects, and essential precautions, providing invaluable insights for patients and healthcare professionals alike.

Understanding Dapagliflozin and Metformin SR: GLIDAPAFLOZIN M 10/500 combines two potent antidiabetic agents: Dapagliflozin and Metformin SR. Dapagliflozin, an SGLT2 inhibitor, reduces renal glucose reabsorption, leading to increased urinary glucose excretion. Metformin SR, a biguanide medication, primarily reduces hepatic glucose production and improves insulin sensitivity in peripheral tissues.

Mechanism of Action: Dapagliflozin inhibits SGLT2 receptors in the renal tubules, promoting urinary glucose excretion and lowering blood sugar levels. Metformin SR decreases hepatic glucose production and improves insulin sensitivity, thereby further reducing blood glucose concentrations. The combined action of Dapagliflozin and Metformin SR offers enhanced glycemic control compared to monotherapy with either agent alone.

Therapeutic Efficacy: Clinical studies have demonstrated the efficacy of GLIDAPAFLOZIN M 10/500 in lowering HbA1c levels, reducing fasting plasma glucose concentrations, and promoting weight loss in patients with type 2 diabetes mellitus. Additionally, this combination therapy may confer cardiovascular benefits and reduce the risk of diabetes-related complications.

Dosage Considerations: The recommended dosage of GLIDAPAFLOZIN M 10/500 may vary depending on individual patient characteristics and glycemic control goals. Typically, it is administered orally once or twice daily with meals. Healthcare providers may initiate treatment with a lower dose and titrate upwards gradually based on blood glucose levels and tolerability.

Potential Side Effects: While generally well-tolerated, GLIDAPAFLOZIN M 10/500 may cause side effects such as urinary tract infections, genital mycotic infections, gastrointestinal upset, or hypoglycemia. Rarely, more serious adverse reactions such as ketoacidosis or lactic acidosis may occur. Patients should be educated about these potential side effects and instructed to seek medical attention if they occur.

Precautions and Safety Measures: Before initiating GLIDAPAFLOZIN M 10/500 therapy, healthcare providers should assess patients for contraindications, including renal impairment, hepatic dysfunction, or hypersensitivity to sulfonylureas or biguanides. Regular monitoring of renal function, liver enzymes, and blood glucose levels is essential to ensure the safety and efficacy of treatment.

Conclusion: GLIDAPAFLOZIN M 10/500 represents a milestone in diabetes management, offering individuals with type 2 diabetes a comprehensive and effective treatment option. By combining Dapagliflozin and Metformin SR, this formulation addresses multiple facets of the disease process, leading to improved glycemic control and better long-term outcomes. Through collaborative efforts between patients and healthcare providers, GLIDAPAFLOZIN M 10/500 continues to pave the way for enhanced diabetes management and improved quality of life. Steris Healthcare Pvt Ltd, established in February 2018 by seasoned professionals in the pharmaceutical sector, operates under the name Sterispharma. Headquartered in Navi Mumbai, the company is certified by WHO, GMP, and ISO. Sterispharma is dedicated to providing high-quality medications at affordable prices across India, adhering to stringent WHO guidelines. They offer an online pharmacy platform for easy medicine purchases and home delivery. The company's mission is to deliver a diverse range of healthcare products catering to the varied needs of the medical community. From advanced treatments and rare condition medications to essential health supplies, Sterispharma aims to meet the extensive demands of the healthcare industry. Their product range covers numerous health fields, including Cardiology, Asthma, Respiratory issues, Nasal conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental care, and Dermatology.

For further information: 

EMAIL:  info@sterispharma.com  / contact@sterispharma.com   

CALL/WHATSAPP: 7877551268, 7849827488

BUY NOW